Leerink Partners analyst Michael Cherny lowered the price target on Medpace (NASDAQ: MEDP) to $485.00 (from $575.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE